Challenges in achieving the guideline-recommended amikacin level for Mycobacterium avium complex pulmonary disease
Background: The addition of aminoglycosides to a macrolide-based regimen is recommended for refractory Mycobacterium avium complex pulmonary disease (MAC-PD). For intravenous amikacin (AMK) administration three times a week, the ATS/ERS/ESCMID/IDSA guidelines recommend targeting a peak serum concent...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405579425000051 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|